SCHEMBL6460552

SCHEMBL6460552

NCC(F)(F)C(=O)Nc1ccc(N2CCOCC2=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 18/20 0.53
▸ PTGS2 P35354 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6460546 0.85 F10 (0.52) F10PTGS2
SCHEMBL28407706 0.80 F10 (0.59) F10PTGS2
SCHEMBL1380646 0.80 F10 (0.62) F10PTGS2
SCHEMBL118847 0.79 F10 (0.60) F10PTGS2
SCHEMBL6453826 0.78 F10 (0.64) F10PTGS2
SCHEMBL5624973 0.78 F10 (0.58) F10PTGS2
SCHEMBL5625339 0.78 F10 (0.58) F10PTGS2
SCHEMBL5628079 0.78 F10 (0.55) F10PTGS2
SCHEMBL5628985 0.78 F10 (0.55) F10PTGS2
SCHEMBL5629329 0.78 F10 (0.55) F10PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1571154-A1 Beta-aminoacid-derivatives as factor Xa inhibitors Aventis Pharma Deutschland GmbH (DE) 2005-09-07 — — EP claimed
EP-1571154-A1 Beta-aminoacid-derivatives as factor Xa inhibitors Aventis Pharma Deutschland GmbH (DE) 2005-09-07 — — EP disclosed
Send feedback